Expression of the PI3K/AKT/mTOR pathway as a prognostic factor in patients with advanced high grade serous ovarian carcinoma treated with neoadjuvant chemotherapy.
| Autor: | Cierniak, S.1, Koktysz, R.1, Jesiotr, M.1, Gąsowska-Bodnar, A.2, Bodnar, L.3 lubo@esculap.pl |
|---|---|
| Zdroj: | European Journal of Gynaecological Oncology. 2019, Vol. 40 Issue 5, p744-751. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|